tetano
Editor, Senior Moderator
J Clin Med
. 2024 Oct 8;13(19):5981.
doi: 10.3390/jcm13195981. Impact of Inhaled Nitric Oxide (iNO) on the Outcome of COVID-19 Associated ARDS
Sandra Emily Stoll[SUP] 1 2 [/SUP], Bernd W Böttiger[SUP] 1 [/SUP], Fabian Dusse[SUP] 1 [/SUP], Nicolas Leister[SUP] 1 [/SUP], Tobias Leupold[SUP] 1 [/SUP], Christoph Menzel[SUP] 1 [/SUP], Remco Overbeek[SUP] 1 [/SUP], Alexander Mathes[SUP] 1 [/SUP]
Affiliations
Background: Inhaled nitric oxide (iNO) can improve oxygenation in acute respiratory syndrome (ARDS), has anti-inflammatory and antithrombotic effects, and can inhibit coronavirus- replication. The study aim was to investigate the impact of iNO in COVID-19 associated ARDS (CARDS) on oxygenation, the length of mechanical ventilation (MV), the level of inflammatory markers and the rate of thrombotic events during ICU stay. Methods: This was a retrospective, observational, monocentric study analyzing the effect of INO (15 parts per million) vs. non-iNO in adult ventilated CARDS patients on oxygenation, the level of inflammatory markers, and the rate of thrombotic events during ICU stay. Within the iNO group, the impact on gas exchange was assessed by comparing arterial blood gas results obtained at different time points. Results: Overall, 19/56 patients were treated with iNO, with no difference regarding sex, age, body mass index, and SOFA-/APACHE II- score between the iNO and non-iNO groups. iNO improved oxygenation in iNO-responders (7/19) and had no impact on inflammatory markers or the rate of thrombotic events but was associated with an increased MV length. Conclusions: iNO was able to improve oxygenation in CARDS in iNO-responders but did not show an impact on inflammatory markers or the rate of thrombotic events, while it was associated with an increased MV length.
Keywords: ARDS; COVID-19 associated ARDS; NO; iNO; inhaled nitric oxide.
. 2024 Oct 8;13(19):5981.
doi: 10.3390/jcm13195981. Impact of Inhaled Nitric Oxide (iNO) on the Outcome of COVID-19 Associated ARDS
Sandra Emily Stoll[SUP] 1 2 [/SUP], Bernd W Böttiger[SUP] 1 [/SUP], Fabian Dusse[SUP] 1 [/SUP], Nicolas Leister[SUP] 1 [/SUP], Tobias Leupold[SUP] 1 [/SUP], Christoph Menzel[SUP] 1 [/SUP], Remco Overbeek[SUP] 1 [/SUP], Alexander Mathes[SUP] 1 [/SUP]
Affiliations
- PMID: 39408041
- DOI: 10.3390/jcm13195981
Background: Inhaled nitric oxide (iNO) can improve oxygenation in acute respiratory syndrome (ARDS), has anti-inflammatory and antithrombotic effects, and can inhibit coronavirus- replication. The study aim was to investigate the impact of iNO in COVID-19 associated ARDS (CARDS) on oxygenation, the length of mechanical ventilation (MV), the level of inflammatory markers and the rate of thrombotic events during ICU stay. Methods: This was a retrospective, observational, monocentric study analyzing the effect of INO (15 parts per million) vs. non-iNO in adult ventilated CARDS patients on oxygenation, the level of inflammatory markers, and the rate of thrombotic events during ICU stay. Within the iNO group, the impact on gas exchange was assessed by comparing arterial blood gas results obtained at different time points. Results: Overall, 19/56 patients were treated with iNO, with no difference regarding sex, age, body mass index, and SOFA-/APACHE II- score between the iNO and non-iNO groups. iNO improved oxygenation in iNO-responders (7/19) and had no impact on inflammatory markers or the rate of thrombotic events but was associated with an increased MV length. Conclusions: iNO was able to improve oxygenation in CARDS in iNO-responders but did not show an impact on inflammatory markers or the rate of thrombotic events, while it was associated with an increased MV length.
Keywords: ARDS; COVID-19 associated ARDS; NO; iNO; inhaled nitric oxide.